Overview

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-01-01

Target enrollment:

Participant gender:

Summary

Safety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances.

Phase:

PHASE3

Details

Lead Sponsor:

Ocuphire Pharma, Inc.

Collaborator:

Viatris Inc.